Pulmonx (LUNG) Stock Chart & Stock Price History $2.78 +0.06 (+2.02%) As of 07/3/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Pulmonx Stock Price Performance The Pulmonx (LUNG) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 57.24%, with a year-to-date return of -59.13%. In the past month, the stock has decreased 12.46%, reflecting recent market activity. As of the latest close, Pulmonx traded at $2.78 with a market cap of $111.72 million and volume of 151,836 shares. Receive LUNG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pulmonx and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.16%1 Month Performance-12.46%3 Month Performance-58.95%Year-To-Date Performance-59.13%1 Year Performance-57.24% LUNG Stock Chart for Sunday, July, 6, 2025 LUNG Chart by TradingView Pulmonx Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$2.78$2.78$2.88$2.74151,836 shs$111.72 million07/03/2025$2.72$2.78+2.02%$2.88$2.74151,836 shs$111.72 million07/02/2025$2.69$2.72+1.12%$2.80$2.68131,696 shs$109.51 million07/01/2025$2.59$2.69+3.86%$2.84$2.56259,613 shs$108.30 million06/30/2025$2.60$2.59-0.38%$2.65$2.52250,540 shs$104.27 million06/27/2025$2.59$2.60+0.39%$2.67$2.56433,765 shs$104.68 million06/26/2025$2.63$2.59-1.52%$2.62$2.50317,131 shs$104.27 million06/25/2025$2.69$2.63-2.23%$2.68$2.57193,433 shs$105.88 million06/24/2025$2.57$2.69+4.67%$2.80$2.55309,661 shs$108.29 million06/23/2025$2.62$2.57-1.91%$2.63$2.51189,927 shs$103.47 million Get the Latest News and Ratings for LUNG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pulmonx and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025$2.75$2.62-4.73%$2.80$2.61409,002 shs$105.48 million06/19/2025$2.75$2.75$2.85$2.62294,202 shs$110.71 million06/18/2025$2.71$2.75+1.48%$2.85$2.62294,202 shs$110.72 million06/17/2025$2.98$2.71-9.06%$2.96$2.70310,201 shs$109.10 million06/16/2025$3.03$2.98-1.65%$3.05$2.94161,296 shs$119.97 million06/13/2025$3.14$3.03-3.50%$3.10$3.00179,455 shs$121.98 million06/12/2025$3.26$3.14-3.68%$3.27$3.13135,798 shs$126.41 million06/11/2025$3.40$3.26-4.12%$3.51$3.26420,978 shs$131.24 million06/10/2025$3.40$3.40$3.52$3.34343,143 shs$136.88 million06/09/2025$3.17$3.40+7.26%$3.45$3.11392,630 shs$136.88 million06/06/2025$2.97$3.17+6.73%$3.56$3.101.04 million shs$127.62 million06/05/2025$3.08$2.97-3.57%$3.10$2.96302,125 shs$119.57 million Related Companies Treace Medical Concepts Stock Chart NeuroPace Stock Chart Outset Medical Stock Chart ClearPoint Neuro Stock Chart Nano-X Imaging Stock Chart ZimVie Stock Chart Sanuwave Health Stock Chart Perspective Therapeutics Stock Chart Nyxoah Stock Chart Alpha Tau Medical Stock Chart Receive LUNG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pulmonx and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LUNG) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulmonx Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulmonx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.